Alimera Sciences Announces National Pricing and Reimbursement Granted for ILUVIEN® for DME in Belgium
ATLANTA, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the...
ATLANTA, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the...
Real-world data published in Clinical Ophthalmology show the safety, efficacy, and durability of effect of OMNI for use in a...
HARTFORD, Conn., Aug. 23, 2021 (GLOBE NEWSWIRE) -- CareCentrix, the leader in health-at-home solutions, today announced the company’s inclusion in...
WESTLAKE VILLAGE, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing...
Solaris Pharma Receives Approval for First Generic Version of Clindagel Solaris Pharma Receives Approval for First Generic Version of Clindagel...
TORONTO, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic...
NEW YORK and VANCOUVER, British Columbia, Aug. 23, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell”...
Based on successfully achieving certain milestones primarily related to the execution of a Phase 3 trial and development of large-scale...
BOTHELL, Wash., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on...
Credit Facility provides financial capacity to pursue accretive growth opportunitiesNew debt lender increases financial flexibility with new source of capitalImproves...
Toronto, Ontario--(Newsfile Corp. - August 23, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the...
Coverage Further Validates Laparoscopic Radiofrequency Ablation for Women with Uterine Fibroids MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader...
Announces Governance Enhancements to Further Align with Best Practice Revises Director Slate to Include Only Individuals Who Are Committed to...
Supporting the Most Robust, Diverse and Longest-Term Body of Clinical Evidence for Any MIGS Technology Multiple 5-, 6-, 7- and...
Life science professional expands Lucira’s management team EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical...
Preclinical data with KIN001 confirm potent antiviral activity against SARS-CoV-2 as well as potent anti-inflammatory and anti-fibrotic activityKIN001 is currently...
One-time treatment option during surgery ideal for patients over 70 who may otherwise receive no radiation or endure side effects...
Data shows that the administration of Rhenium-186 NanoLiposome (186RNL) via convection enhanced delivery for recurrent glioblastoma is well tolerated at...
Toronto, Ontario--(Newsfile Corp. - August 20, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay") and Fio...
OTTAWA, Aug. 20, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced the...